Abstract Views :495 |
PDF Views:0
Authors
Affiliations
1 Cairo University, EG
2 National Laser Institute, Cairo University, EG
3 Department of Plastic Surgery, Matariateaching Hospital, Cairo, EG
4 Nasser Institute Hospital, Cairo, EG
Source
Indian Journal of Public Health Research & Development, Vol 10, No 12 (2019), Pagination: 1440-1445
Abstract
Aim: is to evaluate the results of intralesional bleomycin injection for treatment of haemangiomaand vascular malformation. Indications, limitations, adjustment of dose and results of treatment. Patients and Method: This study was carried out on 40 patients with vascular anomalies; either hemangioma or vascular malformations from both sexes at different age groups. Patients treated with intralesional Bleomycin Injection and treatment response will be evaluated. Results: 26 cases (65%) present significant response which includes complete resolution, excellent and good response; 7 cases (17.5%) presents fair response and 7 cases (17.5%) presents poor response. No cases presents no change or increase in size. Conclusion: Intralesional bleomycin injection (IBI) is a simple, practical and noninvasive method of treatment of vascular anomalies and can considered one of priorities in the treatment of Infantile Hemangiomas and small and medium sized venous malformations.
Keywords
Vascular anomalies, Infantile Hemangioma (IH), Vascular Malformation, Bleomycin and Intralesional Bleomycin Injection (IBI).
